News Image

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Provided By GlobeNewswire

Last update: May 27, 2025

Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations

Will Leverage Deep Pharma Services Expertise as Leader of Lifecore’s Sales Organization Focused on Executing Three-Pronged Growth Strategy

Read more at globenewswire.com

LIFECORE BIOMEDICAL INC

NASDAQ:LFCR (11/19/2025, 2:58:20 PM)

7.49

-0.11 (-1.45%)



Find more stocks in the Stock Screener

Follow ChartMill for more